Atrasentan in Patients With IgA Nephropathy
Public ClinicalTrials.gov record NCT04573478. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
Study identification
- NCT ID
- NCT04573478
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 404 participants
Conditions and interventions
Conditions
Interventions
- Atrasentan Drug
- Placebo Drug
- Zigakibart Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 10, 2020
- Primary completion
- Apr 13, 2028
- Completion
- Apr 13, 2028
- Last update posted
- Jun 3, 2026
2020 – 2028
United States locations
- U.S. sites
- 21
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Comprehensive Research Institute | Alhambra | California | 91754 | — |
| Kidney Disease Medical Group | Glendale | California | 91204 | — |
| Stanford University | Stanford | California | 93405 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| GA Nephrology Associates | Lawrenceville | Georgia | 30046 | — |
| NANI Research, LLC | Hinsdale | Illinois | 60521 | — |
| NANI Research, LLC | Fort Wayne | Indiana | 46804 | — |
| University of Louisville Physicians- Kidney Disease Program | Louisville | Kentucky | 40202 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Intermed Consultants | Minneapolis | Minnesota | 55404 | — |
| Pelican Point Dialysis - DaVita Clinical Research | Las Vegas | Nevada | 89129 | — |
| Capital District Renal Physicians | Clifton Park | New York | 12065 | — |
| Mountain Kidney and Hypertension Associates | Asheville | North Carolina | 28801 | — |
| Brookview Hills Research Associates, LLC | Winston-Salem | North Carolina | 27103 | — |
| Lehigh Valley Hospital | Bethlehem | Pennsylvania | 18017 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Liberty Research Center | Dallas | Texas | 75230 | — |
| El Paso Kidney Specialists | El Paso | Texas | 79925 | — |
| Nephrology Associates Of Northern Virginia | Fairfax | Virginia | 22033 | — |
| Swedish Health Services | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04573478, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04573478 live on ClinicalTrials.gov.